SanoLiBio’s Approach

SanoLiBio develops fully automated solutions to meet the market demand for high throughput screening and diagnostics. A first protoype of our Cell Enricher Single has been shipped in July to our clinical validation Premise Biosystems, Thailand. Market introduction is scheduled for H1 2019. The Cell Enricher Multi will be introduced 2H 2019 and allows to enrich more samples in parallel in a shorter time compared to our first device.